SShortSingh.
Back to feed

Perplexity sees 60% revenue jump in India after Airtel free offer ends

0
·40 views

AI search startup Perplexity experienced a significant revenue surge in India, with earnings climbing approximately 60% following the conclusion of its free access partnership with telecom giant Airtel. The promotional deal had offered Airtel subscribers free access to Perplexity's AI platform, attracting a large wave of new users across the country. Although app downloads dropped once the free offer was no longer available to new users, the remaining user base proved more commercially valuable. The transition suggests that the Airtel campaign successfully converted a meaningful segment of Indian users into paying customers. This outcome highlights India as a strategically important growth market for Perplexity despite the post-promotion decline in new sign-ups.

Read the full story at TechCrunch

This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)

Log in to join the discussion and vote.

Log in

Related stories

0
TechnologyThe Verge ·

Microsoft and Japan dismantle global phishing network behind billion scam messages

Microsoft, in collaboration with Japan's National Police Agency, disrupted a major cybercrime operation. The operation targeted a digital marketplace known as YAM Store and two phishing kits named CoGUI and Iron Man. Since January 2026, these tools facilitated over one billion malicious messages aimed at more than 75,000 organizations globally. The coordinated takedown is intended to significantly reduce the volume of scam texts, such as fake delivery notifications, received by potential victims worldwide.

0
TechnologyTechCrunch ·

German startup TimeTeller develops saliva test to analyze personal circadian rhythms

German startup TimeTeller has created a saliva test kit designed to analyze an individual's circadian rhythm. The company aims to apply this information to the field of personalized medicine. A primary goal is to use the data to help reduce side effects from cancer treatments. The test is intended to make detailed internal clock analysis accessible to the general public.